October 2, 2025

Arcturus Therapeutics Holdings (ARCT): An Investor’s Insight into a Potential 236% Upside

Arcturus Therapeutics Holdings Inc. (ARCT), a biotechnology company headquartered in San Diego, California, is making waves in the healthcare sector with its promising advancements in infectious disease vaccines and treatments..

Aura Biosciences (AURA) Stock Analysis: A Biotech Gem with 245% Upside Potential

Aura Biosciences, Inc. (NASDAQ: AURA) is making waves in the biotechnology sector with its innovative approach to treating solid tumors. As a clinical-stage biotech company based in Boston, Massachusetts, Aura..

Yalla Group Limited (YALA) Stock Analysis: Exploring a 25% Upside Potential in the Emerging MENA Social Networking Market

Yalla Group Limited (NYSE: YALA), a technology pioneer rooted in the United Arab Emirates, stands out as a promising investment in the burgeoning Middle East and North Africa (MENA) tech..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Unpacking the 46.94% Potential Upside

SANUWAVE Health, Inc. (SNWV), a promising player in the healthcare sector, particularly in the medical devices industry, is drawing attention with an impressive potential upside of 46.94%. Headquartered in Eden..

Neurogene Inc. (NGNE) Stock Analysis: Exploring a 193% Potential Upside in Biotechnology

In the fast-evolving landscape of biotechnology, Neurogene Inc. (NASDAQ: NGNE) presents a compelling opportunity for investors seeking exposure to the healthcare sector’s innovative edge. With a focus on developing genetic..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Potential 51% Upside Awaits Investors

Tvardi Therapeutics, Inc. (NASDAQ: TVRD) is making waves in the biotechnology sector with its innovative approach to tackling fibrosis-driven diseases. Based in Sugar Land, Texas, this clinical-stage biopharmaceutical company has..

Alumis Inc. (ALMS): Investor Outlook on a Biotech Stock with a 367% Upside Potential

Alumis Inc. (NASDAQ: ALMS) has emerged as a compelling player in the biotechnology sector, capturing investor attention with a staggering potential upside of 367.98%. This clinical-stage biopharmaceutical company, headquartered in..

Canopy Growth Corporation (CGC): Investor Outlook on a Volatile Cannabis Pioneer

Canopy Growth Corporation (NYSE: CGC), a prominent figure in the cannabis industry, has been a focal point for investors seeking exposure to the burgeoning legal cannabis market. With a market..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Navigating Biotech Opportunities with a 1.97% Potential Upside

iTeos Therapeutics, Inc. (NASDAQ: ITOS) stands at the forefront of the biotechnology sector, with a focus on developing immuno-oncology therapeutics that could revolutionize cancer treatment. Operating as a clinical-stage biopharmaceutical..

Cartesian Therapeutics, Inc. (RNAC): Analyst Ratings Signal Significant 255.75% Upside Potential

For investors keeping a keen eye on the biotechnology sector, Cartesian Therapeutics, Inc. (NASDAQ: RNAC) presents a fascinating opportunity. Specializing in the development of mRNA cell therapies for autoimmune diseases,..

Spok Holdings, Inc. (SPOK) Stock Analysis: Healthcare Communication Leader with a 26.81% Upside Potential

Spok Holdings, Inc. (NASDAQ: SPOK) stands as a significant player in the healthcare communication sector, offering a suite of solutions that streamline workflows for clinicians and enhance patient outcomes. With..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Unveiling a Potential 126% Upside in Women’s Cancer Therapies

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), headquartered in San Francisco, is a clinical-stage biopharmaceutical company making significant strides in the healthcare sector, specifically within the biotechnology industry. With a market capitalization..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: A 38.69% Upside Potential Ignites Investor Interest

ClearPoint Neuro Inc. (NASDAQ: CLPT), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 38.69%, according to recent..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring a Potential 52.98% Upside in the Genomics Market

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors intrigued by the genomics..

Absci Corporation (ABSI) Stock Analysis: A Biotech Gem with 159% Upside Potential

Absci Corporation (NASDAQ: ABSI), a pioneering force in the biotechnology sector, stands out with its compelling investment thesis. Operating at the intersection of artificial intelligence and drug discovery, Absci’s unique..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Exploring a Potential 110% Upside Amidst Healthcare Innovation

Nano-X Imaging Ltd (NASDAQ: NNOX) is carving its niche in the healthcare sector with its innovative medical devices, particularly in the realm of digital imaging. As a company based in..

Mereo BioPharma Group plc (MREO) Stock Analysis: Unveiling a 247% Potential Upside in Biotech

Mereo BioPharma Group plc (NASDAQ: MREO), a UK-based biopharmaceutical company, has captured the attention of investors with its promising pipeline and substantial potential upside. Specializing in the development and commercialization..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 42% Potential Upside in the Medical Devices Sector

Varex Imaging Corporation (VREX), a prominent player in the healthcare sector, is capturing investor attention with a compelling potential upside of 42.27%. The company, headquartered in Salt Lake City, Utah,..

Chevron Corporation (CVX) Stock Analysis: Is a 9.81% Upside Within Reach?

Chevron Corporation (NYSE: CVX), a titan in the energy sector, remains a focal point for investors seeking stability and growth in the oil & gas integrated industry. With a market..

Benitec Biopharma Inc. (BNTC) Stock Analysis: A Potential 77% Upside Awaits Investors

Benitec Biopharma Inc. (BNTC), a clinical-stage biotechnology company, has been capturing the attention of investors with its innovative approach to genetic medicine. Headquartered in Hayward, California, Benitec is at the..

Search

Funds

October 2, 2025

Search

Funds

October 2, 2025

FTSE 100

Funds